NYSE: GSK
Gsk PLC Stock Forecast, Predictions & Price Target

Should I buy or sell GSK stock?

Based on 1 analyst offering ratings for Gsk PLC.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their GSK stock forecasts and price targets.

GSK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-24

1 of 1

GSK vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
GSK$50.05N/AN/AHold
SNY$43.33N/AN/A
BMY$64.10$67.90+5.93%Buy
PFE$27.72$28.36+2.32%Hold
BIIB$217.36$238.38+9.67%Buy

Gsk Stock Forecast FAQ

Is Gsk Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: GSK) stock is to Hold GSK stock.

Out of 1 analyst, 0 (0%) are recommending GSK as a Strong Buy, 0 (0%) are recommending GSK as a Buy, 1 (100%) are recommending GSK as a Hold, 0 (0%) are recommending GSK as a Sell, and 0 (0%) are recommending GSK as a Strong Sell.

If you're new to stock investing, here's how to buy Gsk stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.